| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/07/2011 | CN101642487B Simultaneous extraction and separation process of baicalin and baicalein in baikal skullcap root |
| 09/07/2011 | CN101638430B Anti-tuberculosis CTL epitope peptide |
| 09/07/2011 | CN101607992B Antibacterial peptide separated from cow blood and code sequence and application thereof |
| 09/07/2011 | CN101602787B Alisol A derivative, medicinal composition, preparation method and application thereof |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101590037B Andrographolidume composition and application thereof |
| 09/07/2011 | CN101573118B Aqueous liquid preparation comprising gatifloxacin |
| 09/07/2011 | CN101544632B Lamivudine diastereoselective synthesis method |
| 09/07/2011 | CN101513485B Medicament for treating tinea |
| 09/07/2011 | CN101502550B Filifolium sibiricum effective component extract as well as preparation method and use thereof |
| 09/07/2011 | CN101418334B Diterpenes diterpenoids natural product inhibitor for main protease of coronaviruses such as SARS and screen method thereof |
| 09/07/2011 | CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof |
| 09/07/2011 | CN101417098B External medicine for treating male and female venereal disease |
| 09/07/2011 | CN101411796B Novel use of betelnut and extract thereof in preparing anti-AIDS medicament |
| 09/07/2011 | CN101389607B Substituted arylsulfonamides as antiviral agents |
| 09/07/2011 | CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection |
| 09/07/2011 | CN101361709B 0Long-acting enrofloxacin injection and preparation method thereof |
| 09/07/2011 | CN101328168B Diethylcarbamyl-substituted thiazole dihydropyrimidine |
| 09/07/2011 | CN101278981B Medicament for treating upper respiratory tract infection in children and preparation method thereof |
| 09/07/2011 | CN101274118B Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof |
| 09/07/2011 | CN101269132B Coptis chinensis total alkaloid extracting technique |
| 09/07/2011 | CN101255154B Substituted 2-indoline ketone derivatives as well as preparation method and uses thereof |
| 09/07/2011 | CN101220055B Method for preparing fluoroquinolone compounds containing phosphoric acid ester group |
| 09/07/2011 | CN101194979B Powder medicament for treating herpes stomatitis |
| 09/07/2011 | CN101193882B N-formyl hydroxylamine compounds as PDF inhibitor |
| 09/07/2011 | CN101175531B Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol |
| 09/07/2011 | CN101175474B Methods of reducing microbial contamination |
| 09/07/2011 | CN101167758B Method for preparing antiviral natural polymerization polysaccharide and oligosaccharide |
| 09/07/2011 | CN101011470B Traditional Chinese medicine compound composition for treating hepatitis |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012964 9-substituted 8-oxoadenine compound |
| 09/06/2011 | US8012736 Multi plasmid system for the production of influenza virus |
| 09/06/2011 | US8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | CA2529347C Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2463085C Vaccines against arthropod-borne infectious diseases |
| 09/06/2011 | CA2457983C Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| 09/06/2011 | CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/04/2011 | CA2695337A1 Compositions and methods for inhibition of hiv |
| 09/02/2011 | DE202009017734U1 Zusatzmittel zum Reduzieren von pathogenen Bakterien in einem Stall für Nutztiere Additive for reducing pathogenic bacteria in a barn for livestock |
| 09/01/2011 | WO2011106445A1 Antiviral compounds |
| 09/01/2011 | WO2011106340A1 Pyrazolopyridazine derivatives for the treatment of hepatitis c |
| 09/01/2011 | WO2011106003A1 Synthesis of magnolol and its analogue compounds |
| 09/01/2011 | WO2011105891A1 Combination vaccine for streptococcus |
| 09/01/2011 | WO2011105590A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105431A1 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 09/01/2011 | WO2011105394A1 Method for producing regulatory dendritic cells |
| 09/01/2011 | WO2011105300A1 Antiviral agent |
| 09/01/2011 | WO2011104981A1 Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
| 09/01/2011 | WO2011104900A1 Anti-fungal agent |
| 09/01/2011 | WO2011104562A1 Fungal nail treatment composition |
| 09/01/2011 | WO2011104497A1 Method for the preparation of a novel nanoparticle conjugate |
| 09/01/2011 | WO2011104352A1 Oral lactoferrin in the treatment of severe sepsis |
| 09/01/2011 | WO2011103794A1 Spray for treating diseases caused by human papilloma virus and preparation method thereof |
| 09/01/2011 | WO2011103788A1 (±)-marinopyrrole a and synthesized derivatives thereof for resisting methicillin-resistant staphylococcus aureus |
| 09/01/2011 | WO2011103762A1 Lamivudine oxalate and preparation method thereof |
| 09/01/2011 | WO2011103686A1 CEPHALOSPORIN DERIVATIVES USEFUL AS β-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 09/01/2011 | WO2011056650A9 Methods and compositions for treating and preventing viral infections |
| 09/01/2011 | WO2011049988A3 Indazoles to treat flaviviridae virus infection |
| 09/01/2011 | WO2011041325A3 Methods and compositions for the treatment of viral disorders |
| 09/01/2011 | WO2010127195A3 Treatment of hemoglobin (hbf/hbg) related diseases inhibition of natural antisense transcript to hbf/hbg |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213030 External Preparation For Skin |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213025 Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids |
| 09/01/2011 | US20110213020 Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213005 Methods for treating viral infections |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212990 Novel polymorph of moxifloxacin hydrochloride |
| 09/01/2011 | US20110212988 Tacrolimus preparation for external applications |
| 09/01/2011 | US20110212986 Anti-flavivirus therapeutic |
| 09/01/2011 | US20110212975 Antiviral compounds and methods of making and using thereof |
| 09/01/2011 | US20110212971 Diketo fused azolopiperidines and azolopiperazines as anti-hiv agents |
| 09/01/2011 | US20110212966 Antiviral agents |
| 09/01/2011 | US20110212964 Modulators of pharmacokinetic properties of therapeutics |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/01/2011 | US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 09/01/2011 | US20110212933 Antiseptic Compositions for the Treatment of Infections |
| 09/01/2011 | US20110212918 Boron-containing small molecules |
| 09/01/2011 | US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 09/01/2011 | US20110212912 Optimised formulation of tobramycin for aerosolization |
| 09/01/2011 | US20110212908 Topical compositions and the use thereof |
| 09/01/2011 | US20110212885 Ophthalmic and contact lens solutions containing peptides as preservative |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212197 Plant Extract and Its Therapeutic Use |
| 09/01/2011 | US20110212187 Antimicrobial composition |
| 09/01/2011 | US20110212185 Water that expresses pathogen-resistance genes (pr gene clusters) to encode plant immunoproteins, a method of preventing plant diseases using the water, and a device for producing the water |
| 09/01/2011 | US20110212182 Masked taste pharmaceutical granules/granulates |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |